세계의 신경 수복 및 재생 시장 예측 : 제품 유형별, 병태 유형별, 용도별, 최종 사용자별, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $10.3 billion in 2024 and is expected to reach $25.3 billion by 2030 growing at a CAGR of 16.1% during the forecast period. Nerve repair and regeneration refer to the natural or assisted processes by which damaged or injured nerves in the body are restored to their functional state. This involves the repair of damaged nerve tissue and the regeneration of nerve fibers, allowing for the restoration of sensory and motor functions. These processes can occur spontaneously to some extent in the body, but they can also be facilitated through medical interventions such as surgery, nerve grafting, or the use of regenerative therapies. The ultimate goal is to restore nerve function and facilitate recovery from nerve injuries or disorders.

According to the Alzheimer's Association, in 2022, 6.5 million people aged 65 or more in America were suffering from Alzheimer's disease.

Market Dynamics:

Driver:

Growing geriatric population

The market is experiencing significant growth, largely due to the increasing geriatric population. With advancements in healthcare, more elderly individuals are seeking treatments for nerve-related conditions. This demographic shift has fueled demand for innovative solutions catering to nerve repair and regeneration. As older adults face challenges such as neuropathy and nerve injuries, there's a pressing need for therapies that can restore function and improve quality of life. This trend underscores the market's potential for expansion and innovation.

Restraint:

Limited efficacy of current treatments

The market faces significant challenges due to the limited efficacy of current treatments. Despite advancements, many existing approaches struggle to fully restore nerve function, especially in complex cases. This limitation underscores the pressing need for innovative solutions that can enhance regeneration outcomes and address diverse patient needs. Developing therapies with higher success rates and broader applicability remains a critical goal in overcoming the hurdles faced by the market.

Opportunity:

Technological advancements

Recent advancements in nerve repair and regeneration technology include the development of bioengineered nerve grafts, such as nerve conduits and scaffolds, to promote nerve regeneration. Additionally, innovative approaches like stem cell therapy, gene therapy, and nerve tissue engineering have shown promise in enhancing nerve repair outcomes. Advanced imaging techniques and neurostimulation methods also aid in mapping nerve pathways and facilitating nerve regeneration.

Threat:

High cost of procedures

The market is marked by steep procedure costs, posing significant financial barriers for patients seeking treatment. With expenses often ranging in the thousands, if not tens of thousands, of dollars, accessibility becomes a major concern. These high costs encompass surgical procedures, specialized diagnostics, and post-operative care, amplifying the financial strain on individuals and healthcare systems alike. Addressing this challenge is crucial for ensuring equitable access to essential nerve repair and regeneration therapies.

Covid-19 Impact:

The COVID-19 pandemic significantly affected the Nerve Repair and Regeneration market, causing disruptions in healthcare services and delaying elective procedures. Reduced patient visits and surgical interventions led to a decline in market growth. Supply chain disruptions also hampered the availability of medical devices and treatments. However, with the gradual recovery of healthcare services and increased awareness of nerve injuries, the market is expected to rebound. Innovations in telemedicine and remote patient monitoring might reshape the market dynamics, driving future growth in nerve repair and regeneration technologies.

The biomaterials segment is expected to be the largest during the forecast period

The biomaterials is expected to be the largest during the forecast period. These biomaterials include hydrogels, scaffolds, and conduits, offer promising solutions for repairing damaged nerves and promoting regeneration. The market's expansion is further propelled by rising incidences of nerve injuries, coupled with the increasing adoption of minimally invasive surgical techniques. Additionally, ongoing research efforts and collaborations aim to enhance the efficacy and accessibility of these biomaterials, fostering continued market growth.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period. These facilities are equipped with advanced technologies and staffed by expert medical professionals who focus on restoring nerve function and improving patients' quality of life. From nerve grafting to nerve stimulation therapies, these centers offer comprehensive services tailored to individual needs, driving advancements in neurological medicine and fostering hope for those with nerve injuries or conditions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing prevalence of nerve injuries and disorders, technological advancements, and rising demand for innovative treatment options. Factors such as a well-established healthcare infrastructure, supportive reimbursement policies, and a growing aging population contribute to market expansion. Key players are focusing on developing novel therapies and expanding their product portfolios, further fueling market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to several factors such as increasing incidences of nerve injuries, growing geriatric population, rising awareness about nerve repair treatments, and advancements in healthcare infrastructure and technologies. Additionally, the increasing investments in research and development activities by both government and private organizations are fueling innovation in nerve repair and regeneration technologies in the region.

Key players in the market

Some of the key players in Nerve Repair and Regeneration market include Medtronic, Plc., Synovis Micro Companies Alliance, Axogen Corporation, Checkpoint Surgical, Synapse Biomedical Inc., Polyganics, Boston scientific inc, Nuvectra Corporation, Abbott Laboratories, OrthoMed, Inc NeuroSigma, Inc., Stryker Corporation, Allergan plc, Baxter International Inc., Collagen Matrix, Inc. and Integra LifeSciences Holdings Corporation

Key Developments:

In March 2024, Medtronic announced the launch of the new UNiD(TM) ePRO service in the United States. This solution will change the way patient outcomes are collected for spine surgeons, reducing the burden on clinic staff and patients. Medtronic has partnered with OBERD, a leading practice intelligence data collection company, to provide spine surgeons with an electronic Patient Reported Outcomes (ePRO) system.

In November 2023, Medtronic launched a new frontier in treating high blood pressure. The U.S. Food and Drug Administration (FDA) today approved the Medtronic Symplicity Spyral(TM) renal denervation system for use in the United States. The system, which carries the FDA's Breakthrough Device designation, uses radio frequency to disrupt overactive nerves in the kidneys and help lower blood pressure.

Product Types Covered:

• Biomaterials
• Neuromodulation Devices
• Other Product Types

Condition Types Covered:

• Traumatic Nerve Injuries
• Neurodegenerative Diseases
• Nerve Compression Syndromes
• Peripheral Neuropathies
• Other Condition Types

Applications Covered:

• Nerve Grafting
• Stem Cell Therapy
• Direct Nerve Repair
• Other Applications

End Users Covered:

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Research Laboratories and Academic Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product Type

• 5.1 Introduction
• 5.2 Biomaterials
  • 5.2.1 Nerve Conduits
  • 5.2.2 Nerve Protectors
  • 5.2.3 Nerve Wraps
  • 5.2.4 Nerve Connectors
• 5.3 Neuromodulation Devices
  • 5.3.1 Internal Neurostimulation Devices
    • 5.3.1.1 Spinal Cord Stimulators
    • 5.3.1.2 Deep Brain Stimulators
    • 5.3.1.3 Sacral Nerve Stimulators
    • 5.3.1.4 Vagus Nerve Stimulators
  • 5.3.2 External Neurostimulation Devices
    • 5.3.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
    • 5.3.2.2 Transcranial Magnetic Stimulation (TMS)
    • 5.3.2.3 Respiratory Electrical Stimulation Devices
• 5.4 Other Product Types

6 Global Nerve Repair and Regeneration Market, By Condition Type

• 6.1 Introduction
• 6.2 Traumatic Nerve Injuries
• 6.3 Neurodegenerative Diseases
• 6.4 Nerve Compression Syndromes
• 6.5 Peripheral Neuropathies
• 6.6 Other Condition Types

7 Global Nerve Repair and Regeneration Market, By Application

• 7.1 Introduction
• 7.2 Nerve Grafting
  • 7.2.1 Autografts
  • 7.2.2 Allografts
  • 7.2.3 Xenografts
• 7.3 Stem Cell Therapy
  • 7.3.1 Mesenchymal Stem Cells (MSCs)
  • 7.3.2 Hematopoietic Stem Cells (HSCs)
  • 7.3.3 Neural Stem Cells (NSCs)
• 7.4 Direct Nerve Repair
  • 7.4.1 Epineural Repair
  • 7.4.2 Perineural Repair
  • 7.4.3 Group Fascicular Repair
• 7.5 Other Applications

8 Global Nerve Repair and Regeneration Market, By End User

• 8.1 Introduction
• 8.2 Hospitals and Clinics
• 8.3 Ambulatory Surgical Centers (ASCs)
• 8.4 Research Laboratories and Academic Institutes
• 8.5 Other End Users

9 Global Nerve Repair and Regeneration Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Medtronic, Plc.
• 11.2 Synovis Micro Companies Alliance
• 11.3 Axogen Corporation
• 11.4 Checkpoint Surgical
• 11.5 Synapse Biomedical Inc.
• 11.6 Polyganics
• 11.7 Boston scientific inc
• 11.8 Nuvectra Corporation
• 11.9 Abbott Laboratories
• 11.10 OrthoMed, Inc
• 11.11 NeuroSigma, Inc.
• 11.12 Stryker Corporation
• 11.13 Allergan plc
• 11.14 Baxter International Inc.
• 11.15 Collagen Matrix, Inc.
• 11.16 Integra LifeSciences Holdings Corporation